By Elise Takahama – Seattle Times –
A King County jury has awarded $24 million to the family of a man who died a day after treatment at a Seattle stem cell center.
Mike Trujillo was 62, a longtime electrician who ran an electrical company in Colorado. After being diagnosed with ALS in 2017, he continued to work full time, and hike and exercise often.
In early 2019, he heard about Seattle Stem Cell Center through online marketing, which promoted stem cell treatments for many serious medical conditions, including ALS. Trujillo participated in a free consultation with the center, and became hopeful the therapy could help treat or cure the disease.
At the time, Trujillo was taking Coumadin, a blood-thinning medication, which the lawsuit, filed in King County Superior Court, says he told the center about.
In February 2019, he underwent his first treatment. His second procedure was in early April. He was never told to stop taking his medication during either of the procedures, the complaint says. The April spinal injection ended up causing significant brain bleeding, the complaint alleges, and he was pronounced dead a day later.
